Anavex Life Sciences Corp. (AVXL)
2.535
-0.08
(-3.24%)
USD |
NASDAQ |
Jun 09, 16:00
2.535
0.00 (0.00%)
After-Hours: 20:00
Anavex Life Sciences Shareholders Equity (Quarterly) : 126.62M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Tenaya Therapeutics, Inc. | 106.19M |
| Arrowhead Pharmaceuticals, Inc. | 613.98M |
| Oncolytics Biotech, Inc. | -5.13M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Sarepta Therapeutics, Inc. | 1.505B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 132.99M |
| Total Liabilities (Quarterly) | 6.371M |
| Current Ratio | 20.87 |